Abacus Medicine postpones IPO two days before initial trading
May 31, 2019
Abacus Medicine, a Danish-based pharmaceutical provider, that last week published its intention to go public has postponed the IPO due to unfavourable market conditions. The same happened in fall 2018 where Abacus also postponed its IPO.
ⓘ This story was originally featured in our daily M&A Insights newsletter.